ABSTRACT
OBJECTIVES: To report the genotype-phenotype characteristics, demographic features and clinical outcome of Omani patients with congenital hyperinsulinism (CHI). Methods: We retrospectively analyzed the clinical, biochemical, genotypical, phenotypical characteristics and outcomes of children with CHI who were presented to the pediatric endocrine team in the Royal Hospital, Muscat, Oman between January 2007 and December 2016. Results: Analysis of 25 patients with CHI genetically revealed homozygous mutation in ABCC8 in 23 (92%) patients and 2 patients (8%) with compound heterozygous mutation in ABCC8. Fifteen (60%) patients underwent subtotal pancreatectomy as medical therapy failed and 2 (8%) patients showed response to medical therapy. Three patients expired during the neonatal period, 2 had cardiomyopathy and sepsis, and one had sepsis and severe metabolic acidosis. Out of the 15 patients who underwent pancreatectomy, 6 developed diabetes mellitus, 6 continued to have hypoglycemia and required medical therapy and one had pancreatic exocrine dysfunction post-pancreatectomy, following up with gastroenterology clinic and was placed on pancreatic enzyme supplements, while 2 patients continued to have hypoglycemia and both had abdominal MRI and 18-F-fluoro-L-DOPA positron emission tomography scan (PET-scan), that showed persistent of the disease and started on medical therapy. Conclusion: Mutation in ABCC8 is the most common cause of CHI and reflects the early age of presentation. There is a need for early diagnosis and appropriate therapeutic strategy.
Subject(s)
Congenital Hyperinsulinism/metabolism , Hypoglycemia/metabolism , Apnea/etiology , Apnea/physiopathology , Child, Preschool , Congenital Hyperinsulinism/genetics , Congenital Hyperinsulinism/physiopathology , Congenital Hyperinsulinism/therapy , Diabetes Mellitus/drug therapy , Enzyme Replacement Therapy , Exocrine Pancreatic Insufficiency/drug therapy , Female , Gastrointestinal Agents/therapeutic use , Heterozygote , Homozygote , Humans , Hypoglycemia/complications , Hypoglycemia/physiopathology , Infant , Infant, Newborn , Lethargy/etiology , Lethargy/physiopathology , Male , Mutation , Octreotide/therapeutic use , Oman , Pancreatectomy , Peptides, Cyclic/therapeutic use , Postoperative Complications/drug therapy , Retrospective Studies , Seizures/etiology , Seizures/physiopathology , Sirolimus/therapeutic use , Somatostatin/analogs & derivatives , Somatostatin/therapeutic use , Sulfonylurea Receptors/genetics , Treatment OutcomeABSTRACT
Oncocytic tumors are epithelial neoplasms that occur in various organs, including adrenal glands. Oncocytic adrenocortical adenomas and carcinomas are uncommon but well-known pathological entities in adults. However, generally oncocytic tumors, particularly in the adrenal glands, are very rare in the pediatric age-group. Most oncocytic adrenal tumors are not functional. We present a rare case of right-sided, functional oncocytic adrenocortical adenoma in a 5-year-old boy, who presented with clinical manifestations of precocious puberty and Cushing syndrome. Laparoscopic adrenalectomy showed a well-defined mass weighing 8.4 g and measuring 3 cm in maximum dimension. Histological examination demonstrated no features suggestive of aggressive biological behavior. The patient showed no evidence of recurrent or metastatic disease and continued to have normal serum hormonal levels 28 months following the surgery. In this report, we discuss the clinicopathological characteristics of this rare pathological entity and briefly review the literature on functional oncocytic adrenal tumors in the pediatric population.